Skip to content

Methylene Blue

Based on the available evidence, methylene blue has been investigated for several clinical applications, though the evidence base varies significantly across different conditions.

Antimicrobial and Antiviral Applications

The most substantive clinical evidence comes from investigations into methylene blue's antimicrobial properties. A completed Phase 2 clinical trial (NCT05004805) specifically examined methylene blue as an antiviral treatment for COVID-19, though detailed results are not provided in the available evidence. Additionally, a completed proof-of-concept study (NCT04615936) investigated nasal photodisinfection for COVID-19, which likely involved methylene blue as a photosensitizer.

Photodynamic Therapy for Wound Care

Another area of clinical investigation is photodynamic therapy using methylene blue for wound healing applications. A completed clinical study (NCT06416462) examined the effects of photodynamic therapy on wound quality and tissue repair specifically in diabetic foot conditions. This application leverages methylene blue's photosensitizing properties to potentially enhance wound healing processes.

Limited Clinical Evidence

The majority of the provided evidence focuses on methylene blue's use in environmental applications, particularly for dye removal and photocatalytic processes, rather than clinical therapeutic uses. While these studies demonstrate methylene blue's photochemical properties, they do not provide direct clinical evidence for therapeutic applications.

Important Limitations: The clinical evidence provided is limited to trial registrations without detailed outcomes data. The actual efficacy, safety profiles, dosing regimens, and clinical protocols for these applications cannot be determined from the available evidence. More comprehensive clinical data would be needed to fully characterize methylene blue's therapeutic potential and safety profile for these conditions.

This information is for educational purposes only and should not be used as a substitute for professional medical advice. Consult with healthcare providers for specific medical recommendations.

Free account required

Clinical data requires a free AXIFI account to access clinical data, safety profiles, and research papers.